Nutraplus India is currently trading at Rs. 271.40, up by 17.80 points or 7.02% from its previous closing of Rs. 253.60 on the BSE.
The scrip opened at Rs. 259.50 and has touched a high and low of Rs. 298.00 and Rs. 257.00 respectively. So far 73702 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 298.00 on 04-Aug-2015 and a 52 week low of Rs. 18.05 on 18-Aug-2014.
Last one week high and low of the scrip stood at Rs. 298.00 and Rs. 241.00 respectively. The current market cap of the company is Rs. 324.69 crore.
The promoters holding in the company stood at 39.37% while Institutions and Non-Institutions held 0.03% and 60.60% respectively.
Nutraplus India will start commercial production from first week of September 2015 at Plant N-92, MIDC Tarapur Maharashtra. This is multipurpose Active Pharmaceutical Ingredient (API) plant and set up with the total installed capacity of 360 MT per annum of various kinds of high end multi specialty API products in Therapeutic & Analgesic segment of Pharma industry. These products are used by various Pharma formulation units worldwide to manufacture the Therapeutic & Analgesic category of Pharma products.
Nutraplus India was incorporated as a private limited company in February 1990. The company’s manufacturing unit was commissioned to make APIs and intermediates.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1529.55 |
Dr. Reddys Lab | 6315.00 |
Cipla | 1423.40 |
Zydus Lifesciences | 1021.00 |
Lupin | 1679.75 |
View more.. |